Daewoong Pharmaceutical has secured a generic version of the diabetes treatment Xigduo XR Tab (metformin hydrochloride/dapagliflozin propanediol hydrate) through a transfer and acquisition deal. The drug will be covered by reimbursement and introduced to the market in August.

With the addition of generic Xigduo XR Tab, Daewoong Pharmaceutical now completes the product lineup, as its generic Forxiga 10 mg (dapagliflozin propanediol hydrate) is listed for reimbursement this month.

According to industry sources on July 26th, Daewoong Pharmaceutical's Forxilomet XR Tab 10/1000mg, Forxilomet XR Tab 10/500mg, and Forxilomet XR Tab 5/500mg will be listed for reimbursement starting in August.